FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine. Antibody preparation is disclosed containing IgG, IgA and at least 5 % of IgM antibodies by weight of total amount of antibodies having specific activity of complement activation, wherein in in vitro analysis of antibody preparation it essentially does not form C5a and/or essentially does not form C3a. Use of antibody preparation for preparing medicinal agent for treating immunological disorders or bacterial infection and method of treating patient suffering from immunological disorder or bacterial infection are disclosed.
EFFECT: presented group of inventions provides effective agents and methods of complement activation.
28 cl, 3 dwg, 13 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY PREPARATIONS | 2011 |
|
RU2749732C2 |
| METHOD FOR PREPARING COMPOSITION OF IMMUNOGLOBULINS | 2011 |
|
RU2612899C2 |
| METHOD FOR PRODUCING IMMUNOGLOBULIN COMPOSITION | 2011 |
|
RU2765738C2 |
| METHOD FOR PRODUCING IMMUNOGLOBULIN FOR INTRAVENOUS INTRODUCTION OF IMMUNOGLOBULIN M ENRICHED PREPARATION, AND PREPARATION PREPARED BY SUCH METHOD | 2010 |
|
RU2470664C2 |
| METHOD OF PRODUCING COMPLEX OF IgG, IgM AND IgA IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION | 2012 |
|
RU2492176C1 |
| METHOD OF IGM-CONTAINING IMMUNOGLOBULIN CONCENTRATE PREPARING | 1999 |
|
RU2158136C1 |
| HUMAN IMMUNOGLOBULIN PREPARATION AGAINST CYTOMEGALOVIRUS FOR INTRAVENOUS INTRODUCTION AND METHOD OF ITS OBTAINING | 2009 |
|
RU2404250C1 |
| TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA | 2017 |
|
RU2735680C2 |
| CHIMERIC IMMUNOGLOBULIN PREPARATION WITH SPECIFIC ANTIVIRAL OR ANTIBACTERIAL EFFECT | 2015 |
|
RU2599029C1 |
| IMMUNOGLOBULIN MARKER BASE FOR IMMUNOBIOLOGICAL PREPARATIONS AND WAY OF ITS RECEPTION, SUPPOSITORIES AND OINTMENT FOR PREVENTION AND THERAPY OF BACTERIEMIC AND VIRUS DISEASES | 2007 |
|
RU2361612C1 |
